Home › Vitelliform Macular Dystrophy
Vitelliform Macular Dystrophy clinical trials recruiting in the U.S.
5 studies for Vitelliform Macular Dystrophy are recruiting participants at sites across the United States.
By state
Recently updated studies
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07185256Cell Collection to Study Eye Diseases
RecruitingObservational studyHealthy volunteers welcome
1 Day – 120 Years · All sexes · Updated Sep 22, 2026 · NCT01432847National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases
RecruitingObservational study
1 Day – 120 Years · All sexes · Updated Jun 9, 2026 · NCT06491615Inherited Retinal Degenerative Disease Registry
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated May 19, 2026 · NCT02435940Study of BEST1 Vitelliform Macular Dystrophy
RecruitingObservational study
All ages · All sexes · Updated Jul 30, 2025 · NCT05809635From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.